PRECLINICAL CANCER OF THE
Skin cancer is by far the most common cancer worldwide. While most skin cancers can be treated well if detected early, the determinants of treatment response and relapse are still not fully understood. Furthermore, advanced stages have a high risk of mortality. High-resolution optoacoustic imaging (RSOM) can resolve detailed temporal changes within the tumor microvasculature, revealing neoangiogenesis within the tumor tissue and longitudinal detailed insights into the vascular growth on a microvascular level. In addition, processes immediately after therapy can be monitored, including single vessel occlusion, vascular normalization and ischemic reperfusion – potentially helping to improve skin cancer therapies.